• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Rev Invest Clin . Distinctive features of IncRNA and mRNA between severe and mild patients with influenza a (H1N1) virus pneumonia

tetano

Editor, Senior Moderator
Rev Invest Clin


. 2025 Apr 29;77(2):67-80.
doi: 10.24875/RIC.24000236. Distinctive features of IncRNA and mRNA between severe and mild patients with influenza a (H1N1) virus pneumonia

Dangsheng Xiao[SUP] 1 [/SUP], Jinyou Li[SUP] 1 [/SUP], Xuehui Zhao[SUP] 2 [/SUP], Yongtao Li[SUP] 3 [/SUP], Haifeng Lu[SUP] 3 [/SUP], Jiezuan Yang[SUP] 3 [/SUP]



Affiliations
Free article Abstract

Background: Influenza A virus H1N1 is a significant cause of respiratory infections, leading to severe complications in some patients. Understanding the molecular differences between severe and mild cases can provide insights into the pathogenesis and potential therapeutic targets for H1N1 infections.
Objectives: The objectives of the study were to investigate the transcriptional variances in mRNA and lncRNA between severe and mild cases of H1N1 infection to discern potential markers contributing to the severity of the illness.
Methods: Transcriptome sequencing was conducted on PBMC samples from 4 severe and 4 mild H1N1-infected patients. The transcriptional profiles of mRNA and lncRNA were analyzed to identify differential expression patterns between the two groups.
Results: Analysis revealed 3655 differentially expressed genes (DEGs), including 3147 protein-coding genes and 508 lncRNAs, in severe versus mild H1N1 cases. These genes were linked to essential cellular processes like ribosome assembly and significant signaling pathways such as the MAPK signaling cascade.
Conclusion: The identified DEGs, particularly those associated with ribosome assembly and key signaling pathways, may serve as potential biomarkers for distinguishing between severe and mild H1N1 infections. This research sheds light on the distinct transcriptomic features contributing to the pathogenesis of severe H1N1 infections, offering insights into differential diagnosis and potential therapeutic targets.

Keywords: H1N1. lncRNA. DEGs. Ribosome. MAPK signaling pathway..

 
Back
Top